0000355811false00003558112024-05-162024-05-16

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, DC 20549


FORM 8-K


CURRENT REPORT
Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934


Date of Report (Date of earliest event reported): May 16, 2024


GENTEX CORPORATION
(Exact name of registrant as specified in its charter)
Michigan
0-1023538-2030505
(State or other jurisdiction
of incorporation)		(Commission
File Number)		(IRS Employer
Identification No.)
600 North Centennial Street
Zeeland
Michigan49464
(Address of principal executive offices)(Zip Code)

Registrant's telephone number, including area code: (616) 772-1800
_____________________________________________________________
(Former name or former address, if changed since last report.)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):

☐    Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
☐    Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
☐    Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
☐    Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities registered pursuant to Section 12(b) of the Act:
Title of each classTrading Symbol(s)Name of each exchange on which registered
Common Stock, par value $0.06 per shareGNTXNASDAQ Global Select Market

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§ 230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§ 240.12b-2 of this chapter).

Emerging growth company    ☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐    


Section 5 – Corporate Governance and Management

Item 5.07    Submission of Matters to a Vote of Security Holders.

On May 16, 2024, the Company held its 2024 Annual Meeting of the Shareholders.  The matters listed and described briefly below were submitted to a vote of the shareholders through the solicitation of proxies. The proposals are described in detail in the Company's Proxy Statement filed on April 4, 2024.  The voting results are as follows:

Election of Directors

    The following individuals were elected to serve as directors of the Company to hold office for a one (1) year term expiring in 2025:
NomineeVotes ForVotes WithheldBroker Non-Votes
Mr. Joseph Anderson176,128,79514,703,74216,441,317
Ms. Leslie Brown166,620,55624,211,98116,441,317
Mr. Garth Deur187,057,9653,774,57216,441,317
Mr. Steve Downing187,635,3763,197,16116,441,317
Dr. Bill Pink190,264,313568,22416,441,317
Mr. Richard Schaum179,561,04711,271,49016,441,317
Ms. Kathleen Starkoff187,590,9523,241,58516,441,317
Mr. Brian Walker187,067,7123,764,82516,441,317
Dr. Ling Zang177,326,31913,506,21816,441,317

Proposal to Ratify the Appointment of Ernst & Young LLP as the Company's Auditors for the Fiscal Year Ended December 31, 2024

    The shareholders did ratify the appointment of Ernst & Young LLP to serve as the Company's auditors for the fiscal year ending December 31, 2024:
Votes ForVotes AgainstAbstentionsBroker Non-Votes
196,638,51310,515,357119,984

Proposal to Approve, on an Advisory Basis, the Compensation of the Company's Named Executive Officers

    The shareholders did approve, on an advisory basis, the compensation of the Company's named executive officers:
Votes ForVotes AgainstAbstentionsBroker Non-Votes
182,023,3088,472,589336,64016,441,317

Section 8 – Other Events

Item 8.01 – Other Events.

With Mr. Gary Goode’s term as a Director expiring on May 16, 2024 and not standing for re-election, the Company’s Board of Directors approved Mr. Garth Deur as the chair of the Company’s Audit Committee, and set the Company’s Audit Committee and Compensation Committee at three (3) members.




SIGNATURE

    Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

Dated: May 21, 2024                            GENTEX CORPORATION
                                    (Registrant)


                                By    /s/ Kevin Nash
                                    Kevin Nash
                                    Chief Financial Officer and
                                    Vice President - Finance




v3.24.1.1.u2
Document and Entity Information
May 16, 2024
Cover [Abstract]  
Document Type 8-K
Document Period End Date May 16, 2024
Entity Registrant Name GENTEX CORPORATION
Entity Central Index Key 0000355811
Amendment Flag false
Entity Incorporation, State or Country Code MI
Entity File Number 0-10235
Entity Tax Identification Number 38-2030505
Entity Address, Address Line One 600 North Centennial Street
Entity Address, City or Town Zeeland
Entity Address, State or Province MI
Entity Address, Postal Zip Code 49464
City Area Code 616
Local Phone Number 772-1800
Written Communications false
Soliciting Material false
Pre-commencement Tender Offer false
Pre-commencement Issuer Tender Offer false
Title of 12(b) Security Common Stock, par value $0.06 per share
Trading Symbol GNTX
Security Exchange Name NASDAQ
Entity Emerging Growth Company false
Grafico Azioni Gentex (NASDAQ:GNTX)
Storico
Da Dic 2024 a Gen 2025 Clicca qui per i Grafici di Gentex
Grafico Azioni Gentex (NASDAQ:GNTX)
Storico
Da Gen 2024 a Gen 2025 Clicca qui per i Grafici di Gentex